CELG

Celgene Corporation News Headlines

$93.85
*  
0.58
0.62%
Get CELG Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Revlimid Gets First-Line Myeloma Win But Devil Still In The Details
7/12/2013 3:12:00 PM - Seeking Alpha

Biogen Idec Inc. (BIIB): Today's Most Compelling Stock Buy
7/11/2013 2:03:10 PM - David Moenning

Astex Pharmaceuticals In Focus With Catalyst In The Near Term
7/11/2013 8:01:00 AM - Seeking Alpha

Celgene Is An Exciting Growth Prospect
7/10/2013 1:45:00 PM - Seeking Alpha

Celgene Expanding R&D Portfolio Into Regenerative Medicine
7/8/2013 2:27:00 PM - Seeking Alpha

Immunogen: A Game Changing Stock With Tremendous Upside Potential
7/5/2013 1:57:00 PM - Seeking Alpha

Stocks Seek Direction In The Midst Of Summer Doldrums
7/5/2013 9:49:00 AM - Seeking Alpha

Amgen Puts Onyx Pharmaceuticals In Play
7/2/2013 12:12:00 PM - Investopedia

The Green Light Is On For Soligenix
7/2/2013 11:15:00 AM - Seeking Alpha

Cramer's Mad Money - Noodles & Company Is The Son Of Chipotle (7/1/13)
7/2/2013 6:00:00 AM - Seeking Alpha

Celgene Vs. Johnson & Johnson: The Race In Blood Cancer
7/1/2013 4:17:00 PM - Seeking Alpha

Onyx Pharma Turns Down Amgen offer - Analyst Blog
7/1/2013 11:30:01 AM - Zacks.com

Celgene Inks Oncology Deal - Analyst Blog
6/27/2013 11:31:58 AM - Zacks.com

Celgene presents Revlimid Data - Analyst Blog
6/26/2013 11:30:01 AM - Zacks.com

Pluristem Updates on IC Study - Analyst Blog
6/20/2013 6:08:01 PM - Zacks.com

Sorrento Has Multiple Shots On Goal, Worth A Closer Look
6/20/2013 3:35:00 PM - Seeking Alpha

Data on PCYC's ibrutinib - Analyst Blog
6/20/2013 11:30:01 AM - Zacks.com

IPO Preview: Bluebird Bio
6/19/2013 5:33:00 AM - Seeking Alpha

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
6/18/2013 11:34:00 AM - Seeking Alpha

Good News for Celgene's Pipeline - Analyst Blog
6/18/2013 11:30:01 AM - Zacks.com

Good News for Celgene's Revlimid - Analyst Blog
6/17/2013 11:31:15 AM - Zacks.com

Data on BMY/ AbbVie's elotuzumab - Analyst Blog
6/17/2013 11:30:10 AM - Zacks.com

Apremilast Data Presented by Celgene - Analyst Blog
6/14/2013 11:30:14 AM - Zacks.com

Cramer's Mad Money - The Kids' Portfolio (6/13/13)
6/14/2013 4:28:00 AM - Seeking Alpha

Novartis: Drug Pipeline And New Drug Applications
6/13/2013 4:35:00 PM - Seeking Alpha